Patents by Inventor Marvin S. Antelman

Marvin S. Antelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040265877
    Abstract: The invention is directed to methods for detecting, monitoring and/or diagnosing aberrant cellular proliferation, and disorders associated therewith, such as cancer, and/or infection by microorganisms. The detection, monitoring and/or diagnosis comprises contacting a compound of the invention with a cell or fluid sample. Compound binding confirms the presence of an abnormal cell or a protein associated with an abnormal cell or infection by one or more microorganisms, and/or disorders associated with infection by one or more microorganisms.
    Type: Application
    Filed: April 28, 2004
    Publication date: December 30, 2004
    Applicant: Marantech Holding, LLC
    Inventors: Marvin S. Antelman, Perry W. Antelman
  • Publication number: 20040247696
    Abstract: The present invention relates to a method of preventing, treating, or managing a condition of an animal, such as a mammal. The animal is administered with a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second different valence state, to prevent, treat, or manage the condition, or a symptom thereof.
    Type: Application
    Filed: August 4, 2004
    Publication date: December 9, 2004
    Inventor: Marvin S. Antelman
  • Publication number: 20040022868
    Abstract: Pharmaceutical compositions including tetrasilver tetroxide (Ag4O4), such as in crystalline form, and methods of using such compositions for the prevention, treatment, and management various of dermatological skin conditions and diseases. In one embodiment, these compositions are substantially free of added persulfates. These dermatological conditions and diseases that may be prevented, treated, or managed with the compositions of the invention vary and include, but are not limited to, eczema, psoriasis, dermatitis, disease-induced skin ulcers, undefined tropical diseases, shingles, rashes, bedsores, cold sores, blisters, boils, herpes simplex, acne, pimples, skin chafing, skin cracking, itchiness, skin peeling, and warts.
    Type: Application
    Filed: July 31, 2003
    Publication date: February 5, 2004
    Applicant: Marantech Holding LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6669966
    Abstract: Skin-growth-enhancing compounds and compositions including a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and Ag(I,III) oxide, or a combination thereof. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. Also included are articles containing such compositions, such as wound dressings, and methods for facilitating or enhancing skin growth using these compounds, compositions, and articles, such as for the treatment or management of burns or skin grafts.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: December 30, 2003
    Assignee: Marantech Holding LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6645531
    Abstract: The present invention is directed to pharmaceutical compositions that include a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and optionally Ag(I,III) oxide. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. In addition, the invention relates to methods for prevention, management, or treatment of a condition using these compounds or pharmaceutical compositions including the same.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: November 11, 2003
    Assignee: Marantech Holding LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6579541
    Abstract: The invention relates to a method and composition for destroying or inhibiting proliferation of microbes using oxidative fluorinator compounds. Fluoride salts that do not dissociate completely in aqueous solutions, such as tri- or tetravalent transition metal fluorides, inert gas fluorides, or tri- or tetravalent rare earth fluorides, are effective antimicrobial agents even at levels up to about 20 ppm, when used alone or in conjunction with a strong oxidizer.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: June 17, 2003
    Assignee: Marantech Holding, LLC
    Inventor: Marvin S. Antelman
  • Publication number: 20030095932
    Abstract: The invention relates to a method and composition for destroying or inhibiting proliferation of microbes using oxidative fluorinator compounds. Fluoride salts that do not dissociate completely in aqueous solutions, such as tri- or tetravalent transition metal fluorides, inert gas fluorides, or tri- or tetravalent rare earth fluorides, are effective antimicrobial agents even at levels up to about 20 ppm, when used alone or in conjunction with a strong oxidizer.
    Type: Application
    Filed: March 16, 2001
    Publication date: May 22, 2003
    Inventor: Marvin S. Antelman
  • Patent number: 6485755
    Abstract: The present invention provides methods for preventing, treating, and/or managing one or more cancerous conditions in a patient, such as a human. A multivalent metal oxide, such as Ag(I,III), Cu(I,III), Pr(III,IV), and Bi(III,V) oxides or a pharmaceutically acceptable derivative thereof, may be administered to the patient in an amount and for a period of time which is therapeutically effective to prevent, treat, and/or manage such condition(s). These cancerous conditions include systemic and external cancers, and may also include conditions and symptoms associated with cancer. The present invention also provides a pharmaceutical composition suitable for treating such cancerous conditions. The compositions of the invention may be adapted for at least one of subcutaneous injection, intramuscular injection, intravenous injection, infusion, transdermal, or topical application.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: November 26, 2002
    Assignee: Marantech Holding
    Inventor: Marvin S. Antelman
  • Publication number: 20020127282
    Abstract: Novel pharmaceuticals are described based on multivalent silver compounds containing Ag(II) or Ag(III) capable of killing pathogenic gram positive and negative bacteria, fungi and algae such as E. coli, Staphylococcus aureus and epidermidis, and Candida albicans. The efficacy of these compounds is enhanced by oxidizing agents such as persulfates. They can also be utilized to preserve pharmaceutical, cosmetic and chemical specialty products against these pathogens.
    Type: Application
    Filed: February 5, 2002
    Publication date: September 12, 2002
    Applicant: N. Jonas & Co., Inc. a/k/a N. Jonas & Co.
    Inventor: Marvin S. Antelman
  • Patent number: 6436420
    Abstract: Fibrous textile articles possessing enhanced antimicrobial properties are prepared by the deposition or interstitial precipitation of tetrasilver tetroxide (Ag4O4) crystals within the interstices of fibers, yarns and/or fabrics forming such articles.
    Type: Grant
    Filed: January 5, 2000
    Date of Patent: August 20, 2002
    Assignee: Marantech Holding, LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6258385
    Abstract: The invention relates to the use of electron active molecular crystals comprising tetrasilver tetroxide (Ag4O4) for the treatment and cure of dermatological skin conditions (diseases) ranging from dermatitis, acne and psoiasis to herpes and skin ulcers.
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: July 10, 2001
    Assignee: Marantech Holding, LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6228491
    Abstract: Fibrous textile articles possessing enhanced antimicrobial properties are prepared by the deposition or interstitial precipitation of cobalt (II, III) oxide (Co3O4) crystals within the interstices of fibers, yarns and/or fabrics forming such articles.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: May 8, 2001
    Assignee: Marantech Holding, LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6225009
    Abstract: A non-liquid electrolyte containing electrochemical cell which operates efficiently at room temperature. The cell includes (a) a non-liquid electrolyte in which protons are mobile, (b) an anode active material based on an organic compound which is a source of protons during cell discharge, or an anode active material including a metal whose cation can assume at least two different non-zero oxidation numbers and (c) a solid cathode including a compound which forms an electrochemical couple with the anode. Anode and cathode active materials can be chosen so that the cell has the feature that the electrochemical reactions at the anode and cathode are at least partially reversible. An important feature of the cell is that no thermal activation is required for its operation, therefore, the cell efficiently operates under ambient temperatures.
    Type: Grant
    Filed: May 19, 1998
    Date of Patent: May 1, 2001
    Assignee: E.C.R. -Electro-Chemical Research Ltd.
    Inventors: Niles A Fleischer, Joost Manassen, Joel Lang, Eli Rosh Chodesh, Marvin S. Antelman
  • Patent number: 5676977
    Abstract: The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag.sub.4 O.sub.4) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans.A single intravenous injection of the devices is all that is required for efficacy at levels of about 40 PPM of human blood. The device molecular crystal contains two mono and two trivalent silver ions capable of "firing" electrons capable of electrocuting the AIDS virus, pathogens and ISM. When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function.
    Type: Grant
    Filed: May 31, 1996
    Date of Patent: October 14, 1997
    Assignee: Antelman Technologies Ltd.
    Inventor: Marvin S. Antelman
  • Patent number: 5575900
    Abstract: Opportunistic decorative mass production gold plating solutions are described which are capable of plating gold at concentrations as low as one-half pennyweight per gallon based on an alkaline gold cyanide complex. The low concentration enables ecological operations as well as low working capital inventory operations. The solutions feature high efficiency "put through" replenishment of gold, and non 24 Karat gold deposition capabilities such as 18 and 14 Karats without the necessity of adding metal salts. The solutions operate over a pH range of one to seven without affecting the stability of the gold cyanide complex in the pH range of 1-2.5. A preferred embodiment of the invention comprises an electrolyte mixture of three buffer salts and two chelating agents capable of depositing bright hard 18 Karat gold colored deposits.
    Type: Grant
    Filed: July 3, 1995
    Date of Patent: November 19, 1996
    Assignees: Antelman Technologies Ltd., Tivian Industries, Ltd.
    Inventors: Marvin S. Antelman, Perry W. Antelman
  • Patent number: 5571520
    Abstract: The employment of molecular crystals as bactericidal, viricidal and algicidal devices, and specifically the molecular semiconductor crystal tetrasilver tetroxide Ag.sub.4 O.sub.4 which has two trivalent and two monovalent silver atoms per molecule, and which through this structural configuration generates electronic activity on a molecular scale capable of killing algae and bacteria via the same mechanism as macroscale electron generators.
    Type: Grant
    Filed: August 4, 1994
    Date of Patent: November 5, 1996
    Assignee: Antelman Technologies Ltd.
    Inventor: Marvin S. Antelman
  • Patent number: 5336499
    Abstract: A novel molecular scale device is described which is bactericidal, fungicidal, viricidal and algicidal. The anti-pathogenic properties of the device are attributed to electron activity indigenous to diamagnetic semiconducting crystals of tetrasilver tetroxide (Ag.sub.4 O.sub.4) which contains two monovalent and two trivalent silver ions in each molecular crystal. When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4.times.10.sup.-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM used as preservatives in a variety of formulations ranging from cosmetics to pharmaceuticals. Indeed, they are intended as active ingredients for pharmaceuticals formulated to destroy such pathogens as Staphylococcus aureus, and epidermidis, the latter of which it completely destroys in a nutrient broth culture of about 1 million organisms at 0.
    Type: Grant
    Filed: November 5, 1992
    Date of Patent: August 9, 1994
    Assignee: Antelman Technologies, Ltd.
    Inventor: Marvin S. Antelman
  • Patent number: 5336416
    Abstract: A method of controlling the growth of bacteria and algae in utilitarian bodies of water such as industrial cooling towers, swimming pools and hot tubs is described. The method includes adding to the water trivalent copper compounds including the periodate and chelate complexes of biuret an tris-(hydroxymethyl) aminomethane. These compounds meet EPA standards of killing 100% of select coliforms within 10 minutes and are efficacious at concentrations as low as 5-9 PPM.
    Type: Grant
    Filed: July 12, 1993
    Date of Patent: August 9, 1994
    Assignee: N. Jonas & Co., Inc.
    Inventor: Marvin S. Antelman
  • Patent number: 5223149
    Abstract: A method for controlling the growth of bacteria and algae in utilitarian bodies of water such as industrial cooling towers, swimming pools and hot tubs is described. The method comprises adding to the water novel trivalent silver compounds. Said compounds are light stable and can be supplied as liquid concentrates which will not precipitate any silver whatsoever from saline waters nor will the concentrates stain skin or discolor surfaces. Said compounds meet the rigid EPA standards of killing 100% of select coliforms within ten minutes and are efficacious at concentrations as low as 1-2 PPM.
    Type: Grant
    Filed: May 18, 1992
    Date of Patent: June 29, 1993
    Assignee: N. Jonas & Co., Inc.
    Inventor: Marvin S. Antelman
  • Patent number: 5211855
    Abstract: A novel molecular scale device is described which is bactericidal, fungicidal and algicidal. The antipathogenic properties of the device are attributed to electron activity indigenous to diamagnetic semiconducting crystals of tetrasilver tetroxide (Ag.sub.4 O.sub.4) which contains two monovalent and two trivalent silver ions in each molecular crystal. When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4.times.10.sup.-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM where they can kill 100% of 100 K/cc Streptococcus faecalis, and E. coli colonies in three minutes meeting the ten-minute EPA criteria of 100% kills within ten minutes for swimming pool and hot-tub applications. The devices can be used in utilitarian bodies of water, such as municipal and industrial water reservoirs.
    Type: Grant
    Filed: January 24, 1992
    Date of Patent: May 18, 1993
    Assignee: N. Jonas & Co., Inc.
    Inventor: Marvin S. Antelman